Leptin signaling molecular actions and drug target in hepatocellular carcinoma
- PMID: 25484575
- PMCID: PMC4238752
- DOI: 10.2147/DDDT.S69004
Leptin signaling molecular actions and drug target in hepatocellular carcinoma
Abstract
Previous reports indicate that over 13 different tumors, including hepatocellular carcinoma (HCC), are related to obesity. Obesity-associated inflammatory, metabolic, and endocrine mediators, as well as the functioning of the gut microbiota, are suspected to contribute to tumorigenesis. In obese people, proinflammatory cytokines/chemokines including tumor necrosis factor-alpha, interleukin (IL)-1 and IL-6, insulin and insulin-like growth factors, adipokines, plasminogen activator inhibitor-1, adiponectin, and leptin are found to play crucial roles in the initiation and development of cancer. The cytokines induced by leptin in adipose tissue or tumor cells have been intensely studied. Leptin-induced signaling pathways are critical for biological functions such as adiposity, energy balance, endocrine function, immune reaction, and angiogenesis as well as oncogenesis. Leptin is an activator of cell proliferation and anti-apoptosis in several cell types, and an inducer of cancer stem cells; its critical roles in tumorigenesis are based on its oncogenic, mitogenic, proinflammatory, and pro-angiogenic actions. This review provides an update of the pathological effects of leptin signaling with special emphasis on potential molecular mechanisms and therapeutic targeting, which could potentially be used in future clinical settings. In addition, leptin-induced angiogenic ability and molecular mechanisms in HCC are discussed. The stringent binding affinity of leptin and its receptor Ob-R, as well as the highly upregulated expression of both leptin and Ob-R in cancer cells compared to normal cells, makes leptin an ideal drug target for the prevention and treatment of HCC, especially in obese patients.
Keywords: drug target; hepatocellular carcinoma; leptin; leptin antagonist; leptin signaling; tumor angiogenesis.
Figures
![Figure 1](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/869c/4238752/350bc032f193/dddt-8-2295Fig1.gif)
Similar articles
-
Association of Adipose Tissue and Adipokines with Development of Obesity-Induced Liver Cancer.Int J Mol Sci. 2021 Feb 22;22(4):2163. doi: 10.3390/ijms22042163. Int J Mol Sci. 2021. PMID: 33671547 Free PMC article. Review.
-
Oncogenic role and therapeutic target of leptin signaling in colorectal cancer.Expert Opin Ther Targets. 2014 Aug;18(8):961-71. doi: 10.1517/14728222.2014.926889. Epub 2014 Jun 19. Expert Opin Ther Targets. 2014. PMID: 24946986 Review.
-
Adiponectin antagonizes the oncogenic actions of leptin in hepatocellular carcinogenesis.Hepatology. 2010 Nov;52(5):1713-22. doi: 10.1002/hep.23892. Hepatology. 2010. PMID: 20941777 Free PMC article.
-
Oncogenic role and therapeutic target of leptin signaling in breast cancer and cancer stem cells.Biochim Biophys Acta. 2012 Apr;1825(2):207-22. doi: 10.1016/j.bbcan.2012.01.002. Epub 2012 Jan 24. Biochim Biophys Acta. 2012. PMID: 22289780 Free PMC article. Review.
-
Adipokines and Non-Alcoholic Fatty Liver Disease: Multiple Interactions.Int J Mol Sci. 2017 Jul 29;18(8):1649. doi: 10.3390/ijms18081649. Int J Mol Sci. 2017. PMID: 28758929 Free PMC article. Review.
Cited by
-
Effect of Intermittent versus Chronic Calorie Restriction on Tumor Incidence: A Systematic Review and Meta-Analysis of Animal Studies.Sci Rep. 2016 Sep 22;6:33739. doi: 10.1038/srep33739. Sci Rep. 2016. PMID: 27653140 Free PMC article.
-
Global DNA methylation patterns in Barrett's esophagus, dysplastic Barrett's, and esophageal adenocarcinoma are associated with BMI, gender, and tobacco use.Clin Epigenetics. 2016 Oct 27;8:111. doi: 10.1186/s13148-016-0273-7. eCollection 2016. Clin Epigenetics. 2016. PMID: 27795744 Free PMC article.
-
The causal impact of gut microbiota on circulating adipokine concentrations: a two-sample Mendelian randomization study.Hormones (Athens). 2024 Dec;23(4):789-799. doi: 10.1007/s42000-024-00553-y. Epub 2024 Apr 2. Hormones (Athens). 2024. PMID: 38564143
-
Advances in the Pathogenesis of Metabolic Liver Disease-Related Hepatocellular Carcinoma.J Hepatocell Carcinoma. 2024 Mar 19;11:581-594. doi: 10.2147/JHC.S450460. eCollection 2024. J Hepatocell Carcinoma. 2024. PMID: 38525158 Free PMC article. Review.
-
Association of Adipose Tissue and Adipokines with Development of Obesity-Induced Liver Cancer.Int J Mol Sci. 2021 Feb 22;22(4):2163. doi: 10.3390/ijms22042163. Int J Mol Sci. 2021. PMID: 33671547 Free PMC article. Review.
References
-
- WHO World Health Organization Fact Sheet for World Wide Prevalence of Obesity. 2006. [Accessed November 3, 2014]. Available from: http://www.who.int/mediacentre/factsheets/fs311/en/
-
- James WP. International association for the study of obesity and China. Obes Rev. 2008;9(suppl 1):2–3. - PubMed
-
- Baskin ML, Ard J, Franklin F, Allison DB. Prevalence of obesity in the United States. Obes Rev. 2005;6:5–7. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous